IP Library Granted Patent US 7,195,915
Granted Patent B2
US 7,195,915 · App. 11/284,905 · Granted Mar 27, 2007

Vectors for animal cells and use thereof

Assignee: Kirin Beer Kabushiki Kaisha
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,195,915
App. No.
11/284,905
Granted
Mar 27, 2007
Kind
B2
Abstract

Protein synthesis inhibitor resistance genes (typified by a cycloheximide resistance gene) are capable of imparting resistance to a protein synthesis inhibitor (typified by cycloheximide) to animal cells sensitive to the inhibitor. The genes have a sequence mutated by substitution in a gene encoding a ribosome-constituting protein derived from an animal. The genes may be placed in recombinant vectors, including expression vectors containing the gene together with a foreign protein structural gene.

Claims (9)

1. A process for selecting an animal cell strain resistant to a protein synthesis inhibitor, comprising:

introducing an expression vector containing (A) a protein synthesis inhibitor resistance gene which is capable of imparting cycloheximide resistance to animal cells sensitive to cycloheximide and which encodes the amino acid sequence comprising SEQ ID NO: 11 or a sequence at least 99% homologous thereto, wherein said amino acid sequence contains an amino acid other than proline at the position corresponding to position 54 of SEQ ID NO: 11 and (B) a gene encoding a foreign protein in an expressible state, into animal cells sensitive to cycloheximide,

culturing the cells with the protein synthesis inhibitor cycloheximide, to express the foreign protein, and

selecting the animal cell strain that is resistant to cycloheximide.

2. A process according to claim 1 , wherein the animal cell strain sensitive to cycloheximide is derived from a mammal.

3. A process according to claim 2 , wherein the animal cell is a CHO cell from the ovary of a Chinese hamster.

4. A process according to claim 3 , wherein the animal cell is a CHO cell lacking dihydrofolic acid reductase.

5. A process for producing a protein, characterized by culturing transformed animal cells containing the expression vector defined in claim 1 and collecting a foreign protein expressed by the cells.

6. A process according to claim 1 , wherein the sequence at least 99% homologous encodes a ribosome protein L44, which has the amino acid sequence comprising SEQ ID NO:12.

Assignments (1)
CHANGE OF NAME Recorded Oct 7, 2011
From: KIRIN BEER KABUSHIKI KAISHA
To: KIRIN HOLDINGS KABUSHIKI KAISHA
Reel/Frame 027034/0476 →
Priority Claims (1)
JP 2001-66925 · Mar 9, 2001 · national
Continuity (2)
Division 1047100900
Related Publication 20060078992A1 · Apr 13, 2006